📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Now Diagnostics

1.1 - Company Overview

Now Diagnostics Logo

Now Diagnostics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of rapid, single-drop-of-blood diagnostic tests delivering results within minutes, including ADEXUSDx assays for COVID-19 antibodies, hCG for early pregnancy, syphilis antibodies, elevated acetaminophen, H-FABP for myocardial damage, and methanol detection in blood, plasma, or serum.

Products and services

  • ADEXUSDx hCG Test: An immunoassay for qualitative detection of human chorionic gonadotropin in a single drop of blood, delivering results within minutes to aid early pregnancy diagnosis
  • ADEXUSDx COVID-19 Test: A lateral-flow immunoassay for qualitative detection of antibodies to SARS-CoV-2 in a single drop of blood, yielding results within minutes indicating recent or prior infection
  • ADEXUSDx Syphilis Test: A rapid antibody test for qualitative detection of syphilis antibodies in blood, plasma, or serum, delivering results within minutes from a single drop to aid diagnosis

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Now Diagnostics

Spero Therapeutics Logo

Spero Therapeutics

HQ: United States Website
  • Description: Provider of oral and IV antibiotic therapies for gram-negative infections: Tebipenem HBr for complicated urinary tract infections and acute pyelonephritis to reduce hospitalizations and support transition from IV to home care; SPR720, an oral investigational agent for nontuberculous mycobacterial pulmonary disease; and SPR206, an IV candidate for multidrug-resistant Gram-negative infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spero Therapeutics company profile →
Cytophage Logo

Cytophage

HQ: Canada Website
  • Description: Provider of bacteriophage development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cytophage company profile →
Alphyn Biologics Logo

Alphyn Biologics

HQ: United States Website
  • Description: Provider of proprietary drug therapies for skin diseases, including Zabalafin hydrogel (AB-101a), a steroid-free topical for atopic dermatitis targeting immune and bacterial components; the Zabalafin (AB-101) multi-bioactive platform; and AB-101b in development for Epidermolysis Bullosa to address inflammation, itch, pain, and skin infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alphyn Biologics company profile →
T2 Biosystems Logo

T2 Biosystems

HQ: United States Website
  • Description: Provider of rapid, accurate infectious disease diagnostics, including the T2Dx Instrument, a fully automated system running tests directly from whole blood, the FDA-cleared T2Bacteria Panel for identifying sepsis-causing bacteria without blood culture, and T2Candida for detecting invasive candidiasis from whole blood.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full T2 Biosystems company profile →
Hyglos Logo

Hyglos

HQ: Germany Website
  • Description: Provider of bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria, leveraging bacteriophage biochemical principles to develop target-specific protein tools for healthcare applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hyglos company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Now Diagnostics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Now Diagnostics

2.2 - Growth funds investing in similar companies to Now Diagnostics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Now Diagnostics

4.2 - Public trading comparable groups for Now Diagnostics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Now Diagnostics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Now Diagnostics

What does Now Diagnostics do?

Now Diagnostics is a provider of rapid, single-drop-of-blood diagnostic tests delivering results within minutes, including ADEXUSDx assays for COVID-19 antibodies, hCG for early pregnancy, syphilis antibodies, elevated acetaminophen, H-FABP for myocardial damage, and methanol detection in blood, plasma, or serum.

Who are Now Diagnostics's competitors?

Now Diagnostics's competitors and similar companies include Spero Therapeutics, Cytophage, Alphyn Biologics, T2 Biosystems, and Hyglos.

Where is Now Diagnostics headquartered?

Now Diagnostics is headquartered in United States.

How many employees does Now Diagnostics have?

Now Diagnostics has 1,000 employees 🔒.

When was Now Diagnostics founded?

Now Diagnostics was founded in 2010 🔒.

What sector and industry vertical is Now Diagnostics in?

Now Diagnostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Now Diagnostics

Who are the top strategic acquirers in Now Diagnostics's sector and industry

Top strategic M&A buyers and acquirers in Now Diagnostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Now Diagnostics?

Top strategic M&A buyers groups and sectors for Now Diagnostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Now Diagnostics's sector and industry vertical

Which are the top PE firms investing in Now Diagnostics's sector and industry vertical?

Top PE firms investing in Now Diagnostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Now Diagnostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Now Diagnostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Now Diagnostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Now Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Now Diagnostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Now Diagnostics?

The key public trading comparables and valuation benchmarks for Now Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Now Diagnostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Now Diagnostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Now Diagnostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Now Diagnostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Now Diagnostics's' sector and industry vertical?

Access recent funding rounds and capital raises in Now Diagnostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Now Diagnostics